Fisetin as entry inhibitor in COVID19 infection
Posted: Fri Jan 15, 2021 2:39 pm
https://pubmed.ncbi.nlm.nih.gov/33382023/
TMPRSS2 is gateway for SARS CoV-2 entry into the host cell. It causes proteolytic activation of spike protein and discharge of the peptide into host cell. The TMPRSS2 inhibition could be one of the approaches to stop the viral entry.
In this study, they found that fisetin can bind to TMPRSS2, and therefore potentially can block the entry of the virus.
One more reason for taking Fisetin.
TMPRSS2 is gateway for SARS CoV-2 entry into the host cell. It causes proteolytic activation of spike protein and discharge of the peptide into host cell. The TMPRSS2 inhibition could be one of the approaches to stop the viral entry.
In this study, they found that fisetin can bind to TMPRSS2, and therefore potentially can block the entry of the virus.
One more reason for taking Fisetin.